SCYNEXIS
SCYX
$2.42
Share price
2.77%
Change (1 day)
-7.82%
Change (1 year)
Categories
SCYNEXIS (SCYX) - Cash on Hand
Cash on Hand as of March 2024 : $80.24 M
According to SCYNEXIS's latest financial reports the company has $80.24 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
SCYNEXIS - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $73.5 M | -29.65% |
| 2021-12-31 | $0.10 B | 12.3% |
| 2020-12-31 | $93.04 M | 92.18% |
| 2019-12-31 | $48.41 M | 9.64% |
| 2018-12-31 | $44.15 M | 0.6% |
| 2017-12-31 | $43.89 M | -25.08% |
| 2016-12-31 | $58.58 M | 24.69% |
| 2015-12-31 | $46.98 M | 45.72% |
| 2014-12-31 | $32.24 M | 2199.79% |
| 2013-12-31 | $1.4 M | -41.22% |
| 2012-12-31 | $2.38 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $12.64 M | -84.25% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $0.31 B | 286.83% | 🇺🇸 USA |
 Catalent CTLT | $0.16 B | 101.88% | 🇺🇸 USA |
 KemPharm KMPH | $82.84 M | 3.24% | 🇺🇸 USA |